EyeWorld Weekly, July 17, 2026

➤ First patient enrolled in Phase 3 study of cenegermin-bkbj in NAION ➤ New AI-powered digital health platform ➤ FDA Advisory Committee meeting for discussion of low-dose atropine therapy ➤ Selection of lead clinical candidate for gene therapy for Stargardt disease ➤ ASCRS news and events ➤ EyeWorld article of the week